Venmax Drugs Board just approved Q1 FY27 results: Revenue ₹2.48 Cr, Profit ₹0.12 Cr.

VD

Also, 7.8 lakh share warrants were forfeited due to non-payment, boosting company funds by ₹0.39 Cr.

No comments yet. Be the first.

More from Venmax Drugs and Pharmaceuticals Ltd

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.